Actos Bladder Cancer Settlement

Posted in Drug & Medical Devices on April 30, 2015

Pharmaceutical giant Takeda has agreed to a $2.4 billion settlement to compensate plaintiffs who allege they developed bladder cancer after taking the diabetes medication, Actos® (pioglitazone). Officials at Takeda Pharmaceutical Co. said the offer will resolve a “vast majority” of the more than 8,000 Actos bladder cancer claims. In a press release, the company explained,...